Combining cell and gene therapy to advance cardiac regeneration

References

• Goss. Principles of regeneration. New York: Academic Press; 1969.
   Google Scholar
• Osawa M, Hanada K, Hamada H, et al. Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273(5272):242–245.
   PubMed Web of Science ®Google Scholar
• Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078–1080.
   PubMed Web of Science ®Google Scholar
• Naqvi N, Li M, Calvert JW, et al. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell. 2014;157(4):795–807.
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102.
   PubMed Web of Science ®Google Scholar
• Kajstura J, Urbanek K, Perl S, et al. Cardiomyogenesis in the adult human heart. Circ Res. 2010;107:305–315.
   PubMed Web of Science ®Google Scholar
• Bergmann O, Jovinge S. Cardiac regeneration in vivo: mending the heart from within? Stem Cell Res. 2014;13(3Pt B):523–531.
   PubMedGoogle Scholar
• Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326–335.
   PubMed Web of Science ®Google Scholar
• Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346:5–15.
   PubMed Web of Science ®Google Scholar
• Boström P, Mann N, Wu J, et al. C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell. 2010;143:1072–1083.
   PubMed Web of Science ®Google Scholar
• Bersell K, Arab S, Haring B, et al. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138:257–270.
   PubMed Web of Science ®Google Scholar
• Kühn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962–969.
   PubMed Web of Science ®Google Scholar
• Senyo SE, Steinhauser ML, Pizzimenti CL, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493:433–436.
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763–776.
   PubMed Web of Science ®Google Scholar
• Torella D, Ellison GM, Karakikes I, et al. Resident cardiac stem cells. Cell Mol Life Sci. 2007;64:661–673.
   PubMed Web of Science ®Google Scholar
• Rasmussen TL, Raveendran G, Zhang J, et al. Getting to the heart of myocardial stem cells and cell therapy. Circulation. 2011;123:1771–1779.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kitpos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013;154:827–842.
   PubMed Web of Science ®Google Scholar
• Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847–1857.
   PubMed Web of Science ®Google Scholar
• Zaruba MM, Soonpaa M, Reuter S, et al. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation. 2010;121(18):1992–2000.
   PubMed Web of Science ®Google Scholar
• Jesty SA, Steffey MA, Lee FK, et al. c-Kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A. 2012;109(33):13380–13385.
   PubMed Web of Science ®Google Scholar
• van Berlo JH, Kanisicak O, Maillet M, et al. c-Kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509(7500):337–341.
   PubMed Web of Science ®Google Scholar
• Cai CL, Molkentin JD. The elusive progenitor cell in cardiac regeneration: slip slidin’ away. Circ Res. 2017;120(2):400–406.
   PubMed Web of Science ®Google Scholar
• van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med. 2014;20(12):1386–1393.
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Ellison GM, Torella D. Absence of evidence is not evidence of absence: pitfalls of cre knock-ins in the c-Kit locus. Circ Res. 2014;115(4):415–418.
   PubMed Web of Science ®Google Scholar
• Aquila I, Marino F, Cianflone E, et al. The use and abuse of Cre/Lox recombination to identify adult cardiomyocyte renewal rate and origin. Pharmacol Res. 2017 Jun 24. DOI:10.1016/j.phrs.2017.06.012
   Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95(9):911–921.
   PubMed Web of Science ®Google Scholar
• Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005;433(7026):647–653.
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7):896–908.
   PubMed Web of Science ®Google Scholar
• Limana F, Zacheo A, Mocini D, et al. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res. 2007;101(12):1255–1265.
   PubMed Web of Science ®Google Scholar
• Smits AM, van Vliet P, Metz CH, et al. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc. 2009;4(2):232–243.
   PubMed Web of Science ®Google Scholar
• Chong JJH, Reinecke H, Iwata M, et al. Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev. 2013;22:1932–1943.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;2013;128(16):e240–327.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895–904.
   PubMed Web of Science ®Google Scholar
• Kulandavelu S, Karantalis V, Fritsch J, et al. Pim1 kinase overexpression enhances ckit+ cardiac stem cell cardiac repair following myocardial infarction in swine. J Am Coll Cardiol. 2016;68(22):2454–2464.
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet. 2003;362(9385):697–703.
   PubMed Web of Science ®Google Scholar
• Schenk S, Mal N, Finan A, et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells. 2007;25(1):245–251.
   PubMed Web of Science ®Google Scholar
• Hsieh PC, Segers VF, Davis ME, et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007;13(8):970–974.
   PubMed Web of Science ®Google Scholar
• Don CW, Murry CE. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med. 2013;17(11):1355–1362.
   PubMed Web of Science ®Google Scholar
• Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013;12(6):689–698.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005;112(8):1128–1135.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac protection and functional improvement. FASEB J. 2006;20(6):661–669.
   PubMed Web of Science ®Google Scholar
• Ripa RS, Haack-Sørensen M, Wang Y, et al. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation. 2007;116(11):I24–I30.
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54(24):2277–2286.
   PubMed Web of Science ®Google Scholar
• Traverse JH, McKenna DH, Harvey K, et al. Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. Am Heart J. 2010;160(3):428–434.
   PubMed Web of Science ®Google Scholar
• Duran JM, Makarewich CA, Sharp TE, et al. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res. 2013;113(5):539–552.
   PubMed Web of Science ®Google Scholar
• Mazo M, Hernandez S, Gavira JJ, et al. Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical Swine model of myocardial infarction. Cell Transplantation. 2012;21(12):2723–2733.
   PubMed Web of Science ®Google Scholar
• Shevchenko EK, Makarevich PI, Tsokolaeva ZI, et al. Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle. J Transl Med. 2013;11:138.
   PubMed Web of Science ®Google Scholar
• Rigol M, Solanes N, Roura S, et al. Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest. 2014;44(1):83–92.
   PubMed Web of Science ®Google Scholar
• Johnston PV, Sasano T, Mills K, et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009;120(12):1075–1083.
   PubMed Web of Science ®Google Scholar
• Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010;106(5):971–980.
   PubMed Web of Science ®Google Scholar
• Mishra R, Vijayan K, Colletti EJ, et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation. 2011;123(4):364–373.
   PubMed Web of Science ®Google Scholar
• Maxeiner H, Mufti S, Krehbiehl N, et al. Interleukin-6 contributes to the paracrine effects of cardiospheres cultured from human, murine and rat hearts. J Cell Physiol. 2014;229(11):1681–1689.
   PubMed Web of Science ®Google Scholar
• Xie Y, Ibrahim A, Cheng K, et al. Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells. Stem Cells. 2014;32(9):2397–2406.
   PubMed Web of Science ®Google Scholar
• Korf-Klingebiel M, Reboll MR, Klede S, et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat Med. 2015;21(2):140–149.
   PubMed Web of Science ®Google Scholar
• Rossini A, Frati C, Lagrasta C, et al. Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. Cardiovasc Res. 2011;89(3):650–660.
   PubMed Web of Science ®Google Scholar
• Oskouei BN, Lamirault G, Joseph C, et al. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med. 2012;1(2):116–124.
   PubMed Web of Science ®Google Scholar
• Li TS, Cheng K, Malliaras K, et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol. 2012;59(10):942–953.
   PubMed Web of Science ®Google Scholar
• Zheng SX, Weng YL, Zhou CQ, et al. Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction. Stem Cell Rev. 2013;9(3):339–349.
   PubMed Web of Science ®Google Scholar
• Citro L, Naidu S, Hassan F, et al. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction. PLoS One. 2014;9(12):e116281.
   PubMed Web of Science ®Google Scholar
• Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA. 2007;104(35):14068–14073.
   PubMed Web of Science ®Google Scholar
• Dawn B, Stein AB, Urbanek K, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A. 2005;102(10):3766–3771.
   PubMed Web of Science ®Google Scholar
• Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121(2):293–305.
   PubMed Web of Science ®Google Scholar
• Bolli R, Tang XL, Sanganalmath SK, et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013;128(2):122–131.
   PubMed Web of Science ®Google Scholar
• Bolli R, Chugh AR, D’Amario D, et al. Effect of cardiac stem cells in patients with ischemic cardiomyopathy: interim results of the SCIPIO trial up to 2 years after therapy. Circulation. 2012;126:2784.
   Google Scholar
• Waring CD, Vicinanza C, Papalamprou A, et al. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J. 2014;35(39):2722–2731.
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Ellison GM, Torella D. The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. Stem Cell Res. 2014;13(3 PtB):615–630.
   PubMed Web of Science ®Google Scholar
• Hocine HR, Costa HE, Dam N, et al. Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Sci Rep. 2017;7:41125.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Torella D, Trigueros C, et al. Use of heterologous non-matched cardiac stem cells (CSCs) without immunosuppression as an effective regenerating agent in a porcine model of acute myocardial infarction. Eur Heart J. 2009;30:495 (Abstract Supplement).
   Web of Science ®Google Scholar
• Nor JE, Christensen J, Mooney DJ, et al. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 1999;154(2):375–384.
   PubMed Web of Science ®Google Scholar
• Deuse T, Peter C, Fedak PWM, et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation. 2009;120(1):247–S254.
   Google Scholar
• Lee TJ, Bhang SH, Yang HS, et al. Enhancement of long-term angiogenic efficacy of adipose stem cells by delivery of FGF2. Microvasc Res. 2012;84(1):1–8.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Morishita R, Higaki J, et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens. 1996;14(9):1067–1072.
   PubMed Web of Science ®Google Scholar
• Welch S, Plank D, Witt S, et al. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res. 2002;90(6):641–648.
   PubMed Web of Science ®Google Scholar
• Ma F, Xiao Z, Chen B, et al. Accelerating proliferation of neural stem/progenitor cells in collagen sponges immobilized with engineered basic fibroblast growth factor for nervous system tissue engineering. Biomacromolecules. 2014;15(3):1062–1068.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu H, Liu J, et al. The c-Myb functions as a downstream target of PDGF-mediated survival signal in vascular smooth muscle cells. Biochem Biophys Res Commun. 2007;24;360(2):433–436.
   Web of Science ®Google Scholar
• Haider HK, Ye L, Jiang S, et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med (Berl). 2004;82(8):539–549.
   PubMed Web of Science ®Google Scholar
• Li Z, Guo X, Guan J. A thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions. Biomacromolecules. 2012;13(6):1956–1964.
   PubMed Web of Science ®Google Scholar
• Choi KC, Yoo DS, Cho KS, et al. Effect of single growth factor and growth factor combinations on differentiation of neural stem cells. J Korean Neurosurg Soc. 2008;44(6):375–381.
   PubMed Web of Science ®Google Scholar
• Minato A, Ise H, Goto M, et al. Cardiac differentiation of embryonic stem cells by substrate immobilization of insulin-like growth factor binding protein 4 with elastin-like polypeptides. Biomaterials. 2012;33(2):515–523.
   PubMed Web of Science ®Google Scholar
• Xue Y, Yan Y, Gong H, et al. Insulin-like growth factor binding protein 4 enhances cardiomyocytes induction in murine induced pluripotent stem cells. J Cell Biochem. 2014;115(9):1495–1504.
   PubMed Web of Science ®Google Scholar
• Song H, Song BW, Cha MJ, et al. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther. 2010;10(3):309–319.
   PubMed Web of Science ®Google Scholar
• Gude N, Joyo E, Toko H, et al. Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells. Basic Res Cardiol. 2015;110:29.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011;58(9):977–986.
   PubMed Web of Science ®Google Scholar
• Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005;97:663–673.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Melo LG, et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells. 2009;27:971–979.
   PubMed Web of Science ®Google Scholar
• Muraski JA, Rota M, Misao Y, et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med. 2007;13:1467–1475.
   PubMed Web of Science ®Google Scholar
• Tsujita Y, Muraski J, Shiraishi I, et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2006;103:11946–11951.
   PubMed Web of Science ®Google Scholar
• Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006;14:840–850.
   PubMed Web of Science ®Google Scholar
• Rota M, Boni A, Urbanek K, et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res. 2005;97:1332–1341.
   PubMed Web of Science ®Google Scholar
• Shiraishi I, Melendez J, Ahn Y, et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res. 2004;94:884–891.
   PubMed Web of Science ®Google Scholar
• Gude N, Muraski J, Rubio M, et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res. 2006;99:381–388.
   PubMed Web of Science ®Google Scholar
• Mirotsou M, Zhang Z, Deb A, et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA. 2007;104:1643–1648.
   PubMed Web of Science ®Google Scholar
• Chen J, Somanath PR, Razorenova O, et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11:1188–1196.
   PubMed Web of Science ®Google Scholar
• Ackah E, Yu J, Zoellner S, et al. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest. 2005;115:2119–2127.
   PubMed Web of Science ®Google Scholar
• Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90:1243–1250.
   PubMed Web of Science ®Google Scholar
• Camper-Kirby D, Welch S, Walker A, et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res. 2001;88:1020–1027.
   PubMed Web of Science ®Google Scholar
• Fischer KM, Din S, Gude N, et al. Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circ Res. 2011;108(8):960–970.
   PubMed Web of Science ®Google Scholar
• Mohsin S, Khan M, Toko H, et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol. 2012;60:1278–1287.
   PubMed Web of Science ®Google Scholar
• de la Pompa JL, Epstein JA. Coordinating tissue interactions: notch signaling in cardiac development and disease. Dev Cell. 2012;22:244–254.
   PubMed Web of Science ®Google Scholar
• High FA, Epstein JA. The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet. 2008;9:49–61.
   PubMed Web of Science ®Google Scholar
• Campa VM, Gutierrez-Lanza R, Cerignoli F, et al. Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J Cell Biol. 2008;183:129–141.
   PubMed Web of Science ®Google Scholar
• Gude NA, Emmanuel G, Wu W, et al. Activation of Notch-mediated protective signaling in the myocardium. Circ Res. 2008;102:1025–1035.
   PubMed Web of Science ®Google Scholar
• Kratsios P, Catela C, Salimova E, et al. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circ Res. 2010;106:559–572.
   PubMed Web of Science ®Google Scholar
• Nemir M, Metrich M, Plaisance I, et al. The Notch pathway controls fibrotic and regenerative repair in the adult heart. Eur Heart J. 2014;35(32):2174–2185.
   PubMed Web of Science ®Google Scholar
• Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res. 2010;107:429–441.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Nadal-Ginard B, Torella D. Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment. J Cardiovasc Transl Res. 2012;5(5):667–677.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872.
   PubMed Web of Science ®Google Scholar
• Pinto AR, Ilinykh A, Ivey MJ, et al. Revisiting cardiac cellular composition. Circ Res. 2016;118(3):400–409.
   PubMed Web of Science ®Google Scholar
• Li XH, Li Q, Jiang L, et al. Generation of functional human cardiac progenitor cells by high-efficiency protein transduction. Stem Cells Transl Med. 2015;4:1415–1424.
   PubMed Web of Science ®Google Scholar
• Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142:375–386.
   PubMed Web of Science ®Google Scholar
• Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485:599–604.
   PubMed Web of Science ®Google Scholar
• Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110:1465–1473.
   PubMed Web of Science ®Google Scholar
• Christoforou N, Chellappan M, Adler AF, et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One. 2013;8:e63577.
   PubMed Web of Science ®Google Scholar
• Muraoka N, Yamakawa H, Miyamoto K, et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. Embo J. 2013;33:1565–1581.
   Web of Science ®Google Scholar
• Wang L, Liu Z, Yin C, et al. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res. 2015;116:237–244.
   PubMed Web of Science ®Google Scholar
• Zhou H, Dickson ME, Kim MS, et al. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes. Natl Acad Sci USA. 2015;112:11864–11869.
   PubMed Web of Science ®Google Scholar
• Andrée B, Zweigerdt R. Directing cardiomyogenic differentiation and transdifferentiation by ectopic gene expression - direct transition or reprogramming detour? Curr Gene Ther. 2016;16(1):14–20.
   PubMed Web of Science ®Google Scholar
• Fu Y, Huang C, Xu X, et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res. 2015;25:1013–1024.
   PubMed Web of Science ®Google Scholar
• Muraoka N, Ieda M. Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. Annu Rev Physiol. 2014;76:21–37.
   PubMed Web of Science ®Google Scholar
• Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485:593–598.
   PubMed Web of Science ®Google Scholar
• Inagawa K, Miyamoto K, Yamakawa H, et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012;111:1147–1156.
   PubMed Web of Science ®Google Scholar
• Urnov FD, Rebar EJ, Holmes MC, et al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2010;11(9):636–646.
   PubMed Web of Science ®Google Scholar
• Bogdanove AJ, Voytas DF. TAL effectors: customizable proteins for DNA targeting. Science. 2011;333(6051):1843–1846.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Smith JR, Maguire S, Davis LA, et al. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells. 2008;26(2):496–504.
   PubMed Web of Science ®Google Scholar
• Hsu PD, Scott DA, Weinstein JA, et al. DNA targeting specificity of RNA guided Cas9 nucleases. Nat Biotechnol. 2013;31(9):827–832.
   PubMed Web of Science ®Google Scholar
• Fu Y, Foden JA, Khayter C, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31(9):822–826.
   PubMed Web of Science ®Google Scholar
• Kim D, Bae S, Park J, et al. Digenome-seq: genome-wide profiling of CRISPR Cas9 off-target effects in human cells. Nat Methods. 2015;12(3):237–243.
   PubMed Web of Science ®Google Scholar
• Bonora G, Plath K, Denholtz M. A mechanistic link between gene regulation and genome architecture in mammalian development. Curr Opin Genet Dev. 2014;27:92–101.
   PubMed Web of Science ®Google Scholar
• Consortium EP, Dunham I, Kundaje A, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
   PubMed Web of Science ®Google Scholar
• Yue F, Cheng Y, Breschi A, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515:355–364.
   PubMed Web of Science ®Google Scholar
• Ounzain S, Crippa S, Pedrazzini T. Small and long noncoding RNAs in cardiac homeostasis and regeneration. Biochim Biophys Acta. 2013;1833:923–933.
   PubMed Web of Science ®Google Scholar
• Gama-Carvalho M, Andrade J, Bras-Rosario L. Regulation of cardiac cell fate by microRNAs: implications for heart regeneration. Cells. 2014;3:996–1026.
   PubMedGoogle Scholar
• Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med. 2014;6:239ps233.
   Web of Science ®Google Scholar
• Glass C, Singla DK. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol. 2011;301(5):2038–2049.
   Web of Science ®Google Scholar
• Glass C, Singla DK. ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium. Mol Cell Biochem. 2011;357:135–141.
   PubMed Web of Science ®Google Scholar
• Hosoda T, Zheng H, Cabral-da-Silva M, et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation. 2011;123:1287–1296.
   PubMed Web of Science ®Google Scholar
• Shen X, Soibam B, Benham A, et al. MiR-322/-503 cluster is expressed in the earliest cardiac progenitor cells and drives cardiomyocyte specification. Proc Natl Acad Sci U S A. 2016;113(34):9551–9556.
   PubMed Web of Science ®Google Scholar
• Sirish P, Lopez JE, Li N, et al. MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol. 2012;52:264–272.
   PubMed Web of Science ®Google Scholar
• Huang F, Li ML, Fang ZF, et al. Overexpression of microRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction. Cardiology. 2013;125(1):18–30.
   PubMed Web of Science ®Google Scholar
• Xu J, Huang Z, Lin L, et al. miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation. Sci China Life Sci. 2014;57(10):989–997.
   PubMed Web of Science ®Google Scholar
• Eulalio A, Mano M, Dal Ferro M, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012;492(7429):376–381.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20:300–307.
   PubMed Web of Science ®Google Scholar
• Hu W, Alvarez-Dominguez JR, Lodish HF. Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep. 2012;13:971–983.
   PubMed Web of Science ®Google Scholar
• Flynn RA, Chang HY. Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell. 2014;14:752–761.
   PubMed Web of Science ®Google Scholar
• Klattenhoff CA, Scheuermann JC, Surface LE, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 2013;152:570–583.
   PubMed Web of Science ®Google Scholar
• Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013;24(2):206–214.
   PubMed Web of Science ®Google Scholar
• Jiang W, Liu Y, Liu R, et al. The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression. Cell Rep. 2015;11(1):137–148.
   PubMed Web of Science ®Google Scholar
• Viereck J, Kumarswamy R, Foinquinos A, et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med. 2016;8(326):326ra22.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285(23):17442–17452.
   PubMed Web of Science ®Google Scholar
• Okoye IS, Coomes SM, Pelly VS, et al. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity. 2014;41(1):89–103.
   PubMed Web of Science ®Google Scholar
• Maring JA, Beez CM, Falk V, et al. Myocardial regeneration via progenitor cell-derived exosomes. Stem Cells Int. 2017;2017(Article ID 7849851):10. pages.
   Google Scholar
• Barile L, Lionetti V, Cervio E, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;103(4):530–541.
   PubMed Web of Science ®Google Scholar
• Ibrahim AGE, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2014;2(5):606–619.
   PubMed Web of Science ®Google Scholar
• Golpanian S, Wolf A, Hatzistergos KE, et al. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127–1168.
   PubMed Web of Science ®Google Scholar